These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The distinctive cytology and disease evolution of blastic plasmacytoid dendritic cell neoplasm. Fernandes F; Barreira R; Cortez J; Silveira M; Bain BJ Am J Hematol; 2018 Nov; 93(11):1431-1432. PubMed ID: 30020546 [No Abstract] [Full Text] [Related]
14. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm. Zhang X; Sun J; Yang M; Wang L; Jin J Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682 [TBL] [Abstract][Full Text] [Related]
15. Blastic Plasmocytoid Dendritic Cell Neoplasm With Skin and Myeloid Location. Mizia-Malarz A; Sobol-Milejska G J Pediatr Hematol Oncol; 2018 Jan; 40(1):e29-e31. PubMed ID: 28060117 [TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity. Lim MS; Lemmert K; Enjeti A BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132 [TBL] [Abstract][Full Text] [Related]
17. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset. Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340 [TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations. Kurt H; Khoury JD; Medeiros LJ; Huh YO Br J Haematol; 2018 May; 181(3):305. PubMed ID: 29411884 [No Abstract] [Full Text] [Related]